Life Sciences
CO2 incubator with built-in roller
Crafted with precision by Wiggens, the CO2 incubator emerges as essential tool for various experimental pursuits, from cultivating animal cells to hatching and germinating processes. With rapid heating, swift temperature recovery, and precise temperature control, this premium incubator ensures optimal conditions for cell growth and research.
Its innovative design features electric heating wires surrounding the chamber, ensuring uniform heat distribution. With dry-wall insulation, maintenance is minimised while temperature stability is maximised. A base heater maintains water in a tray for humidity control, while a circulation fan ensures even moisture dispersion. Additionally, front door and frame heaters prevent condensation, maintaining clarity for observation.
Partnering seamlessly with the CO2 incubator, the Celrol Elite roller apparatus offers configurations from 5 to 88 bottle positions, facilitating cell attachment culture. This versatile apparatus accommodates standard plastic bottles, providing scalability and convenience for researchers. The roller culture technique, utilising gentle
rotation, enhances gas exchange and promotes cell growth.
For high-demand applications like vaccine production, the Celrol Elite can be expanded with additional layers, accommodating up to 11 tiers of bottles. Wiggens supports this system with options for battery backup, SMS alarm notifications, and direct printer connections for streamlined reporting. With its adaptability to standard cell culture bottles, the Celrol Elite roller apparatus offers a versatile solution for a wide array of biotechnological endeavours.
More information online:
ilmt.co/PL/zz7Q and
ilmt.co/PL/pKbB 62298pr@reply-direct.com Novel reagents drive breakthroughs in Parkinson’s and sleep disorder research
In a recent blog post, AMSBIO sheds light on the ground-breaking strides achieved in Parkinson’s disease research, hypersomnia studies, and eco-friendly microbial ester production facilitated by their innovative BioPORTER®, Detachin™, and SoluLyse™ reagents. These reagents play a pivotal role in elevating research efficiency, precision, and reproducibility.
A collaborative initiative led by Dr Wenjing Wang at the University of Michigan and Dr Xiaobo Mao of Johns Hopkins University School of Medicine has propelled significant advancements in potential therapeutics for Parkinson’s disease. The utilisation of the BioPORTER® protein delivery reagent kit enabled seamless transduction of α-syn preformed fibrils to HEK293T cells, unravelling the relationship between α-syn aggregation and PFFNB2. BioPORTER® utilises biocompatible polymers to encapsulate and shield proteins during delivery, ensuring stability and activity for more accurate and reproducible outcomes.
Dr Andrew Jenkins and his team at the University of Saint Joseph are trailblazers in repurposing compounds to address sleep disorders, particularly hypersomnia. Employing Detachin™ Cell Detachment Solution, the researchers prepared cells for electrophysiological analysis, ensuring high cell viability
and functionality through a reliable detachment process. This step is crucial in cell culture experiments, and Detachin™ minimises the risk of altered cell behaviour.
Microbial production of short-chain esters presents an eco-friendly alternative to chemical synthesis, yet challenges in low yields persist. Dr Arul M. Varman at Arizona State University and Dr Ryan Davis from Sandia National Laboratories harnessed the SoluLyse™ Bacterial Protein Extraction Reagent to streamline and expedite the extraction of high-quality protein from E. coli. This efficient formulation ensures optimal cell lysis without compromising protein integrity, addressing the challenge of low yields in microbial ester production.
Dr Maja Petkovic, Business Unit Manager at AMSBIO, emphasised the transformative impact of these reagents, stating: “Replacing basic life science reagents with products like BioPORTER®, Detachin™, and SoluLyse™ can lead to significant improvements in your research outcomes, offering enhanced performance and convenience for more reliable and reproducible results.”
Read the full blog post for comprehensive insights. For further details on innovative products for cellular and microbial research, contact AMSBIO or visit their website. More information online:
ilmt.co/PL/XOLA
62154pr@reply-direct.com Cutting-edge automation solutions for life sciences research
MGI Tech Co, Ltd (MGI), a leading provider of cutting-edge tools for life science and healthcare research, has unveiled a strategic expansion of its automation product lines, catering to sample pre-treatment, sample preparation, and integrated testing at SLAS2024 and Medlab Middle East 2024. Leveraging its expertise in genetic sequencing and multi-omics, MGI’s innovative solutions target the increasing demand for high-throughput, efficient, and reliable processes in precision medicine, agriculture, and healthcare.
Sample pre-treatment: Building upon its successful COVID testing portfolio, MGI introduces the High-throughput Automated Sample Transfer Processing System MGISTP-7000 and the Automated Sample Transfer Processing System MGISTP-3000. These solutions, spanning a broader spectrum of samples and assays, encompass sample collection and extraction, with a focus on enabling swift and accurate DNA/RNA extraction - a pivotal step for downstream analysis.
Sample preparation: MGI’s sample preparation offerings feature a range of systems for nucleic acid library construction. Highlights
include the High-throughput Automated Sample Preparation System MGISP-960, the Automated Sample Preparation System MGISP-100, and the upgraded MGISP-Smart 8 system with ProcessGo software, enhancing integration and user-friendly features. The DNBeLab-D4, a revolutionary automated lab-on-a-chip system, employs advanced microfluidics technology for unparalleled precision in digital PCR applications. The MGI-Glab system, designed for large-scale projects, can process thousands of samples per day, delivering tailored solutions for clinical laboratories, research institutes, and biotechnology companies.
Integrated testing: The MGIFLP-L50 system, MGI’s integrated testing solution, stands out as a modular sequencing workstation that streamlines the entire sequencing workflow. This fully automated system supports diverse research and applications in microbiology, reproductive health, and beyond.
MGI’s expansion underscores its commitment to intelligent innovation in life sciences, offering advanced tools that enhance efficiency, accuracy, and research turnaround times. By eliminating bottlenecks with comprehensive workflow solutions, MGI empowers researchers to focus on result analysis rather than labour-intensive tasks.
Duncan Yu, President of MGI, expressed: “MGI is proud to announce the expansion of our automation product lines, providing advanced solutions to our life science and healthcare partners. Our vision includes increased automation and intelligent features, empowering researchers for data-driven decision-making and contributing to societal advancement through continuous innovation.”
More information online:
ilmt.co/PL/V2x3 61949pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
